APO Research
Talk to an analyst

APO RESEARCH · REPORT

Short Bowel Syndrome (SBS) Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Short Bowel Syndrome (SBS) Drugs Industry Growth and Trends Forecast to 2032

20 December 202595 pages

Choose your research edition.

Industry ResearchShort Bowel Syndrome (SBS) Drugs Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Short Bowel Syndrome (SBS) Drugs Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Short Bowel Syndrome (SBS) Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Short Bowel Syndrome (SBS) Drugs Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Short Bowel Syndrome (SBS) Drugs Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Short Bowel Syndrome (SBS) Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Short Bowel Syndrome (SBS) Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Short Bowel Syndrome (SBS) Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Short Bowel Syndrome (SBS) Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Short Bowel Syndrome (SBS) Drugs include Takeda, Merck, Zealand Pharma, Sancilio Pharmaceuticals, OxThera, Nutrinia, Naia Pharmaceuticals, Emmaus Medical and Ardelyx, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Short Bowel Syndrome (SBS) Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Short Bowel Syndrome (SBS) Drugs market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Short Bowel Syndrome (SBS) Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Short Bowel Syndrome (SBS) Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Short Bowel Syndrome (SBS) Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Short Bowel Syndrome (SBS) Drugs Market by Company

Takeda

Merck

Zealand Pharma

Sancilio Pharmaceuticals

OxThera

Nutrinia

Naia Pharmaceuticals

Emmaus Medical

Ardelyx

Short Bowel Syndrome (SBS) Drugs Segment by Type

Glutamine

Growth Hormone

Glucagon-Like Peptide-2 (GLP-2)

Other

Short Bowel Syndrome (SBS) Drugs Segment by Application

Hospitals

Clinics

Retail Pharmacies

Short Bowel Syndrome (SBS) Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Short Bowel Syndrome (SBS) Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Short Bowel Syndrome (SBS) Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Short Bowel Syndrome (SBS) Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Short Bowel Syndrome (SBS) Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Short Bowel Syndrome (SBS) Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Glutamine Table 2. Major Company of Growth Hormone Table 3. Major Company of Glucagon-Like Peptide-2 (GLP-2) Table 4. Major Company of Other Table 5. Global Short Bowel Syndrome (SBS) Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Short Bowel Syndrome (SBS) Drugs Sales by Type (2021-2026) & (K Units) Table 7. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share in Volume by Type (2021-2026) Table 8. Global Short Bowel Syndrome (SBS) Drugs Sales by Type (2021-2026) & (US$ Million) Table 9. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share in Value by Type (2021-2026) Table 10. Global Short Bowel Syndrome (SBS) Drugs Price by Type (2021-2026) & (US$/Unit) Table 11. Global Short Bowel Syndrome (SBS) Drugs Sales by Type (2027-2032) & (K Units) Table 12. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share in Volume by Type (2027-2032) Table 13. Global Short Bowel Syndrome (SBS) Drugs Sales by Type (2027-2032) & (US$ Million) Table 14. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share in Value by Type (2027-2032) Table 15. Global Short Bowel Syndrome (SBS) Drugs Price by Type (2027-2032) & (US$/Unit) Table 16. North America Short Bowel Syndrome (SBS) Drugs Sales by Type (2021-2026) & (K Units) Table 17. North America Short Bowel Syndrome (SBS) Drugs Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Short Bowel Syndrome (SBS) Drugs Sales by Type (2021-2026) & (K Units) Table 19. Europe Short Bowel Syndrome (SBS) Drugs Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Short Bowel Syndrome (SBS) Drugs Sales by Type (2021-2026) & (K Units) Table 21. Asia-Pacific Short Bowel Syndrome (SBS) Drugs Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Short Bowel Syndrome (SBS) Drugs Sales by Type (2021-2026) & (K Units) Table 23. Latin America Short Bowel Syndrome (SBS) Drugs Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Sales by Type (2021-2026) & (K Units) Table 25. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Sales by Type (2021-2026) & (US$ Million) Table 26. Short Bowel Syndrome (SBS) Drugs Industry Trends Table 27. Short Bowel Syndrome (SBS) Drugs Industry Drivers Table 28. Short Bowel Syndrome (SBS) Drugs Industry Opportunities and Challenges Table 29. Short Bowel Syndrome (SBS) Drugs Industry Restraints Table 30. Global Short Bowel Syndrome (SBS) Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Company (2021-2026) Table 32. Global Short Bowel Syndrome (SBS) Drugs Sales by Company (2021-2026) & (K Units) Table 33. Global Short Bowel Syndrome (SBS) Drugs Sales Share by Company (2021-2026) Table 34. Global Short Bowel Syndrome (SBS) Drugs Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global Short Bowel Syndrome (SBS) Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Short Bowel Syndrome (SBS) Drugs Major Company Production Sites and Headquarters Table 37. Global Short Bowel Syndrome (SBS) Drugs Company, Product Type & Application Table 38. Global Short Bowel Syndrome (SBS) Drugs Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Short Bowel Syndrome (SBS) Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Short Bowel Syndrome (SBS) Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Short Bowel Syndrome (SBS) Drugs Sales by Region (2021-2026) & (K Units) Table 43. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share in Volume by Region (2021-2026) Table 44. Global Short Bowel Syndrome (SBS) Drugs Sales by Region (2021-2026) & (US$ Million) Table 45. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share in Value by Region (2021-2026) Table 46. Global Short Bowel Syndrome (SBS) Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global Short Bowel Syndrome (SBS) Drugs Sales by Region (2027-2032) & (K Units) Table 48. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share in Volume by Region (2027-2032) Table 49. Global Short Bowel Syndrome (SBS) Drugs Sales by Region (2027-2032) & (US$ Million) Table 50. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share in Value by Region (2027-2032) Table 51. Global Short Bowel Syndrome (SBS) Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global Short Bowel Syndrome (SBS) Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Short Bowel Syndrome (SBS) Drugs Sales by Application (2021-2026) & (K Units) Table 54. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share in Volume by Application (2021-2026) Table 55. Global Short Bowel Syndrome (SBS) Drugs Sales by Application (2021-2026) & (US$ Million) Table 56. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share in Value by Application (2021-2026) Table 57. Global Short Bowel Syndrome (SBS) Drugs Price by Application (2021-2026) & (US$/Unit) Table 58. Global Short Bowel Syndrome (SBS) Drugs Sales by Application (2027-2032) & (K Units) Table 59. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share in Volume by Application (2027-2032) Table 60. Global Short Bowel Syndrome (SBS) Drugs Sales by Application (2027-2032) & (US$ Million) Table 61. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share in Value by Application (2027-2032) Table 62. Global Short Bowel Syndrome (SBS) Drugs Price by Application (2027-2032) & (US$/Unit) Table 63. North America Short Bowel Syndrome (SBS) Drugs Sales by Application (2021-2026) & (K Units) Table 64. North America Short Bowel Syndrome (SBS) Drugs Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Short Bowel Syndrome (SBS) Drugs Sales by Application (2021-2026) & (K Units) Table 66. Europe Short Bowel Syndrome (SBS) Drugs Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Short Bowel Syndrome (SBS) Drugs Sales by Application (2021-2026) & (K Units) Table 68. Asia-Pacific Short Bowel Syndrome (SBS) Drugs Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Short Bowel Syndrome (SBS) Drugs Sales by Application (2021-2026) & (K Units) Table 70. Latin America Short Bowel Syndrome (SBS) Drugs Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Sales by Application (2021-2026) & (K Units) Table 72. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Sales by Application (2021-2026) & (US$ Million) Table 73. Takeda Company Information Table 74. Takeda Business Overview Table 75. Takeda Short Bowel Syndrome (SBS) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Takeda Short Bowel Syndrome (SBS) Drugs Product Portfolio Table 77. Takeda Recent Development Table 78. Merck Company Information Table 79. Merck Business Overview Table 80. Merck Short Bowel Syndrome (SBS) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Merck Short Bowel Syndrome (SBS) Drugs Product Portfolio Table 82. Merck Recent Development Table 83. Zealand Pharma Company Information Table 84. Zealand Pharma Business Overview Table 85. Zealand Pharma Short Bowel Syndrome (SBS) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Zealand Pharma Short Bowel Syndrome (SBS) Drugs Product Portfolio Table 87. Zealand Pharma Recent Development Table 88. Sancilio Pharmaceuticals Company Information Table 89. Sancilio Pharmaceuticals Business Overview Table 90. Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Product Portfolio Table 92. Sancilio Pharmaceuticals Recent Development Table 93. OxThera Company Information Table 94. OxThera Business Overview Table 95. OxThera Short Bowel Syndrome (SBS) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. OxThera Short Bowel Syndrome (SBS) Drugs Product Portfolio Table 97. OxThera Recent Development Table 98. Nutrinia Company Information Table 99. Nutrinia Business Overview Table 100. Nutrinia Short Bowel Syndrome (SBS) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Nutrinia Short Bowel Syndrome (SBS) Drugs Product Portfolio Table 102. Nutrinia Recent Development Table 103. Naia Pharmaceuticals Company Information Table 104. Naia Pharmaceuticals Business Overview Table 105. Naia Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Naia Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Product Portfolio Table 107. Naia Pharmaceuticals Recent Development Table 108. Emmaus Medical Company Information Table 109. Emmaus Medical Business Overview Table 110. Emmaus Medical Short Bowel Syndrome (SBS) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Emmaus Medical Short Bowel Syndrome (SBS) Drugs Product Portfolio Table 112. Emmaus Medical Recent Development Table 113. Ardelyx Company Information Table 114. Ardelyx Business Overview Table 115. Ardelyx Short Bowel Syndrome (SBS) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Ardelyx Short Bowel Syndrome (SBS) Drugs Product Portfolio Table 117. Ardelyx Recent Development Table 118. North America Short Bowel Syndrome (SBS) Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 119. North America Short Bowel Syndrome (SBS) Drugs Sales by Country (2021-2026) & (K Units) Table 120. North America Short Bowel Syndrome (SBS) Drugs Sales Market Share by Country (2021-2026) Table 121. North America Short Bowel Syndrome (SBS) Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 122. North America Short Bowel Syndrome (SBS) Drugs Sales Market Share Forecast by Country (2027-2032) Table 123. North America Short Bowel Syndrome (SBS) Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. North America Short Bowel Syndrome (SBS) Drugs Market Size by Country (2021-2026) & (US$ Million) Table 125. North America Short Bowel Syndrome (SBS) Drugs Market Share by Country (2021-2026) Table 126. North America Short Bowel Syndrome (SBS) Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. North America Short Bowel Syndrome (SBS) Drugs Market Share Forecast by Country (2027-2032) Table 128. Europe Short Bowel Syndrome (SBS) Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 129. Europe Short Bowel Syndrome (SBS) Drugs Sales by Country (2021-2026) & (K Units) Table 130. Europe Short Bowel Syndrome (SBS) Drugs Sales Market Share by Country (2021-2026) Table 131. Europe Short Bowel Syndrome (SBS) Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 132. Europe Short Bowel Syndrome (SBS) Drugs Sales Market Share Forecast by Country (2027-2032) Table 133. Europe Short Bowel Syndrome (SBS) Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Europe Short Bowel Syndrome (SBS) Drugs Market Size by Country (2021-2026) & (US$ Million) Table 135. Europe Short Bowel Syndrome (SBS) Drugs Market Share by Country (2021-2026) Table 136. Europe Short Bowel Syndrome (SBS) Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Europe Short Bowel Syndrome (SBS) Drugs Market Share Forecast by Country (2027-2032) Table 138. Asia-Pacific Short Bowel Syndrome (SBS) Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 139. Asia-Pacific Short Bowel Syndrome (SBS) Drugs Sales by Country (2021-2026) & (K Units) Table 140. Asia-Pacific Short Bowel Syndrome (SBS) Drugs Sales Market Share by Country (2021-2026) Table 141. Asia-Pacific Short Bowel Syndrome (SBS) Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 142. Asia-Pacific Short Bowel Syndrome (SBS) Drugs Sales Market Share Forecast by Country (2027-2032) Table 143. Asia-Pacific Short Bowel Syndrome (SBS) Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Asia-Pacific Short Bowel Syndrome (SBS) Drugs Market Size by Country (2021-2026) & (US$ Million) Table 145. Asia-Pacific Short Bowel Syndrome (SBS) Drugs Market Share by Country (2021-2026) Table 146. Asia-Pacific Short Bowel Syndrome (SBS) Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Asia-Pacific Short Bowel Syndrome (SBS) Drugs Market Share Forecast by Country (2027-2032) Table 148. Latin America Short Bowel Syndrome (SBS) Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 149. Latin America Short Bowel Syndrome (SBS) Drugs Sales by Country (2021-2026) & (K Units) Table 150. Latin America Short Bowel Syndrome (SBS) Drugs Sales Market Share by Country (2021-2026) Table 151. Latin America Short Bowel Syndrome (SBS) Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 152. Latin America Short Bowel Syndrome (SBS) Drugs Sales Market Share Forecast by Country (2027-2032) Table 153. Latin America Short Bowel Syndrome (SBS) Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Latin America Short Bowel Syndrome (SBS) Drugs Market Size by Country (2021-2026) & (US$ Million) Table 155. Latin America Short Bowel Syndrome (SBS) Drugs Market Share by Country (2021-2026) Table 156. Latin America Short Bowel Syndrome (SBS) Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Latin America Short Bowel Syndrome (SBS) Drugs Market Share Forecast by Country (2027-2032) Table 158. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 159. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Sales by Country (2021-2026) & (K Units) Table 160. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Sales Market Share by Country (2021-2026) Table 161. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 162. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Sales Market Share Forecast by Country (2027-2032) Table 163. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Market Size by Country (2021-2026) & (US$ Million) Table 165. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Market Share by Country (2021-2026) Table 166. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Market Share Forecast by Country (2027-2032) Table 168. Key Raw Materials Table 169. Raw Materials Key Suppliers Table 170. Short Bowel Syndrome (SBS) Drugs Distributors List Table 171. Short Bowel Syndrome (SBS) Drugs Customers List Table 172. Research Programs/Design for This Report Table 173. Authors List of This Report Table 174. Secondary Sources Table 175. Primary Sources List of Figures Figure 1. Short Bowel Syndrome (SBS) Drugs Image Figure 2. Global Short Bowel Syndrome (SBS) Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Short Bowel Syndrome (SBS) Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Short Bowel Syndrome (SBS) Drugs Sales (2021-2032) & (K Units) Figure 5. Glutamine Image Figure 6. Global Glutamine Sales YoY Growth (2021-2032) & (K Units) Figure 7. Growth Hormone Image Figure 8. Global Growth Hormone Sales YoY Growth (2021-2032) & (K Units) Figure 9. Glucagon-Like Peptide-2 (GLP-2) Image Figure 10. Global Glucagon-Like Peptide-2 (GLP-2) Sales YoY Growth (2021-2032) & (K Units) Figure 11. Other Image Figure 12. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 13. Global Short Bowel Syndrome (SBS) Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Short Bowel Syndrome (SBS) Drugs Market Share by Type 2025 VS 2032 Figure 15. North America Short Bowel Syndrome (SBS) Drugs Sales Market Share in Volume by Type in 2025 Figure 16. North America Short Bowel Syndrome (SBS) Drugs Sales Market Share in Value by Type in 2025 Figure 17. Europe Short Bowel Syndrome (SBS) Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Europe Short Bowel Syndrome (SBS) Drugs Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Short Bowel Syndrome (SBS) Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Short Bowel Syndrome (SBS) Drugs Sales Market Share in Value by Type in 2025 Figure 21. Latin America Short Bowel Syndrome (SBS) Drugs Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Short Bowel Syndrome (SBS) Drugs Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Short Bowel Syndrome (SBS) Drugs Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Hospitals Image Figure 28. Global Hospitals Sales YoY Growth (2021-2032) & (K Units) Figure 29. Clinics Image Figure 30. Global Clinics Sales YoY Growth (2021-2032) & (K Units) Figure 31. Retail Pharmacies Image Figure 32. Global Retail Pharmacies Sales YoY Growth (2021-2032) & (K Units) Figure 33. Global Short Bowel Syndrome (SBS) Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Short Bowel Syndrome (SBS) Drugs Market Share by Application 2025 VS 2032 Figure 35. North America Short Bowel Syndrome (SBS) Drugs Sales Market Share in Volume by Application in 2025 Figure 36. North America Short Bowel Syndrome (SBS) Drugs Sales Market Share in Value by Application in 2025 Figure 37. Europe Short Bowel Syndrome (SBS) Drugs Sales Market Share in Volume by Application in 2025 Figure 38. Europe Short Bowel Syndrome (SBS) Drugs Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Short Bowel Syndrome (SBS) Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Short Bowel Syndrome (SBS) Drugs Sales Market Share in Value by Application in 2025 Figure 41. Latin America Short Bowel Syndrome (SBS) Drugs Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Short Bowel Syndrome (SBS) Drugs Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Sales Market Share in Value by Application in 2025 Figure 45. North America Short Bowel Syndrome (SBS) Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. North America Short Bowel Syndrome (SBS) Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Short Bowel Syndrome (SBS) Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Short Bowel Syndrome (SBS) Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Short Bowel Syndrome (SBS) Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Europe Short Bowel Syndrome (SBS) Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Short Bowel Syndrome (SBS) Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Short Bowel Syndrome (SBS) Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Short Bowel Syndrome (SBS) Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Asia-Pacific Short Bowel Syndrome (SBS) Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Short Bowel Syndrome (SBS) Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Short Bowel Syndrome (SBS) Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Short Bowel Syndrome (SBS) Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Latin America Short Bowel Syndrome (SBS) Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Short Bowel Syndrome (SBS) Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Short Bowel Syndrome (SBS) Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Short Bowel Syndrome (SBS) Drugs Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Short Bowel Syndrome (SBS) Drugs Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Glutamine
  • Growth Hormone
  • Glucagon-Like Peptide-2 (GLP-2)
  • Other
Applications
  • Hospitals
  • Clinics
  • Retail Pharmacies
Companies covered
  • Takeda
  • Merck
  • Zealand Pharma
  • Sancilio Pharmaceuticals
  • OxThera
  • Nutrinia
  • Naia Pharmaceuticals
  • Emmaus Medical
  • Ardelyx

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Short Bowel Syndrome (SBS) Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Short Bowel Syndrome (SBS) Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Short Bowel Syndrome (SBS) Drugs Market by Type
  6. 1.3.1 Glutamine
  7. 1.3.2 Growth Hormone
  8. 1.3.3 Glucagon-Like Peptide-2 (GLP-2)
  9. 1.3.4 Other
  10. 1.4 Global Short Bowel Syndrome (SBS) Drugs Market Size by Type
  11. 1.4.1 Global Short Bowel Syndrome (SBS) Drugs Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Short Bowel Syndrome (SBS) Drugs Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Short Bowel Syndrome (SBS) Drugs Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Short Bowel Syndrome (SBS) Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Short Bowel Syndrome (SBS) Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Short Bowel Syndrome (SBS) Drugs Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Short Bowel Syndrome (SBS) Drugs Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Short Bowel Syndrome (SBS) Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Short Bowel Syndrome (SBS) Drugs Industry Trends
  2. 2.2 Short Bowel Syndrome (SBS) Drugs Industry Drivers
  3. 2.3 Short Bowel Syndrome (SBS) Drugs Industry Opportunities and Challenges
  4. 2.4 Short Bowel Syndrome (SBS) Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Short Bowel Syndrome (SBS) Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Short Bowel Syndrome (SBS) Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Short Bowel Syndrome (SBS) Drugs Price (2021-2026)
  4. 3.4 Global Short Bowel Syndrome (SBS) Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Short Bowel Syndrome (SBS) Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Short Bowel Syndrome (SBS) Drugs Company, Product Type & Application
  7. 3.7 Global Short Bowel Syndrome (SBS) Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Short Bowel Syndrome (SBS) Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Short Bowel Syndrome (SBS) Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Short Bowel Syndrome (SBS) Drugs Tier 1, Tier 2, and Tier 3
4 Short Bowel Syndrome (SBS) Drugs Regional Status and Outlook
  1. 4.1 Global Short Bowel Syndrome (SBS) Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Short Bowel Syndrome (SBS) Drugs Historic Market Size by Region
  3. 4.2.1 Global Short Bowel Syndrome (SBS) Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Short Bowel Syndrome (SBS) Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Short Bowel Syndrome (SBS) Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Short Bowel Syndrome (SBS) Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Short Bowel Syndrome (SBS) Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Short Bowel Syndrome (SBS) Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Short Bowel Syndrome (SBS) Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Short Bowel Syndrome (SBS) Drugs by Application
  1. 5.1 Short Bowel Syndrome (SBS) Drugs Market by Application
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.1.3 Retail Pharmacies
  5. 5.2 Global Short Bowel Syndrome (SBS) Drugs Market Size by Application
  6. 5.2.1 Global Short Bowel Syndrome (SBS) Drugs Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Short Bowel Syndrome (SBS) Drugs Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Short Bowel Syndrome (SBS) Drugs Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Short Bowel Syndrome (SBS) Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Short Bowel Syndrome (SBS) Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Short Bowel Syndrome (SBS) Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Short Bowel Syndrome (SBS) Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Short Bowel Syndrome (SBS) Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Takeda
  2. 6.1.1 Takeda Company Information
  3. 6.1.2 Takeda Business Overview
  4. 6.1.3 Takeda Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Takeda Short Bowel Syndrome (SBS) Drugs Product Portfolio
  6. 6.1.5 Takeda Recent Developments
  7. 6.2 Merck
  8. 6.2.1 Merck Company Information
  9. 6.2.2 Merck Business Overview
  10. 6.2.3 Merck Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Merck Short Bowel Syndrome (SBS) Drugs Product Portfolio
  12. 6.2.5 Merck Recent Developments
  13. 6.3 Zealand Pharma
  14. 6.3.1 Zealand Pharma Company Information
  15. 6.3.2 Zealand Pharma Business Overview
  16. 6.3.3 Zealand Pharma Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Zealand Pharma Short Bowel Syndrome (SBS) Drugs Product Portfolio
  18. 6.3.5 Zealand Pharma Recent Developments
  19. 6.4 Sancilio Pharmaceuticals
  20. 6.4.1 Sancilio Pharmaceuticals Company Information
  21. 6.4.2 Sancilio Pharmaceuticals Business Overview
  22. 6.4.3 Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Product Portfolio
  24. 6.4.5 Sancilio Pharmaceuticals Recent Developments
  25. 6.5 OxThera
  26. 6.5.1 OxThera Company Information
  27. 6.5.2 OxThera Business Overview
  28. 6.5.3 OxThera Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 OxThera Short Bowel Syndrome (SBS) Drugs Product Portfolio
  30. 6.5.5 OxThera Recent Developments
  31. 6.6 Nutrinia
  32. 6.6.1 Nutrinia Company Information
  33. 6.6.2 Nutrinia Business Overview
  34. 6.6.3 Nutrinia Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Nutrinia Short Bowel Syndrome (SBS) Drugs Product Portfolio
  36. 6.6.5 Nutrinia Recent Developments
  37. 6.7 Naia Pharmaceuticals
  38. 6.7.1 Naia Pharmaceuticals Company Information
  39. 6.7.2 Naia Pharmaceuticals Business Overview
  40. 6.7.3 Naia Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Naia Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Product Portfolio
  42. 6.7.5 Naia Pharmaceuticals Recent Developments
  43. 6.8 Emmaus Medical
  44. 6.8.1 Emmaus Medical Company Information
  45. 6.8.2 Emmaus Medical Business Overview
  46. 6.8.3 Emmaus Medical Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Emmaus Medical Short Bowel Syndrome (SBS) Drugs Product Portfolio
  48. 6.8.5 Emmaus Medical Recent Developments
  49. 6.9 Ardelyx
  50. 6.9.1 Ardelyx Company Information
  51. 6.9.2 Ardelyx Business Overview
  52. 6.9.3 Ardelyx Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Ardelyx Short Bowel Syndrome (SBS) Drugs Product Portfolio
  54. 6.9.5 Ardelyx Recent Developments
7 North America by Country
  1. 7.1 North America Short Bowel Syndrome (SBS) Drugs Sales by Country
  2. 7.1.1 North America Short Bowel Syndrome (SBS) Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Short Bowel Syndrome (SBS) Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Short Bowel Syndrome (SBS) Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Short Bowel Syndrome (SBS) Drugs Market Size by Country
  6. 7.2.1 North America Short Bowel Syndrome (SBS) Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Short Bowel Syndrome (SBS) Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Short Bowel Syndrome (SBS) Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Short Bowel Syndrome (SBS) Drugs Sales by Country
  2. 8.1.1 Europe Short Bowel Syndrome (SBS) Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Short Bowel Syndrome (SBS) Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Short Bowel Syndrome (SBS) Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Short Bowel Syndrome (SBS) Drugs Market Size by Country
  6. 8.2.1 Europe Short Bowel Syndrome (SBS) Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Short Bowel Syndrome (SBS) Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Short Bowel Syndrome (SBS) Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Short Bowel Syndrome (SBS) Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Short Bowel Syndrome (SBS) Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Short Bowel Syndrome (SBS) Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Short Bowel Syndrome (SBS) Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Short Bowel Syndrome (SBS) Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Short Bowel Syndrome (SBS) Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Short Bowel Syndrome (SBS) Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Short Bowel Syndrome (SBS) Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Short Bowel Syndrome (SBS) Drugs Sales by Country
  2. 10.1.1 South America Short Bowel Syndrome (SBS) Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Short Bowel Syndrome (SBS) Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Short Bowel Syndrome (SBS) Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Short Bowel Syndrome (SBS) Drugs Market Size by Country
  6. 10.2.1 South America Short Bowel Syndrome (SBS) Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Short Bowel Syndrome (SBS) Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Short Bowel Syndrome (SBS) Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Short Bowel Syndrome (SBS) Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Short Bowel Syndrome (SBS) Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Short Bowel Syndrome (SBS) Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Short Bowel Syndrome (SBS) Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Short Bowel Syndrome (SBS) Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Short Bowel Syndrome (SBS) Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Short Bowel Syndrome (SBS) Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Short Bowel Syndrome (SBS) Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Short Bowel Syndrome (SBS) Drugs Value Chain Analysis
  2. 12.1.1 Short Bowel Syndrome (SBS) Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Short Bowel Syndrome (SBS) Drugs Production Mode & Process
  7. 12.2 Short Bowel Syndrome (SBS) Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Short Bowel Syndrome (SBS) Drugs Distributors
  10. 12.2.3 Short Bowel Syndrome (SBS) Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst